RMC-7977
Pre-clinical- Indications
- Non-small cell lung cancer, Colorectal cancer, Pancreatic ductal adenocarcinoma
Company intelligence / Profile preview
GenenDesign provides one of the largest PDX-based platforms globally, supporting oncology drug discovery, biomarker identification, and precision medicine. The company enables pharmaceutical companies and researchers to test candidate drugs in clinically relevant tumor models before entering human trials. No direct clinical results as it does not develop its own therapeutics pipeline but supports client programs with robust preclinical data generation.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GenenDesign.